Suchergebnisse - "Dupilumab"

PubPharm (72)

1

Long-Term Safety of Dupilumab in Patients With Moderate-to-Severe Asthma : TRAVERSE Continuation Study

enthalten in: The journal of allergy and clinical immunology. In practice | 2024

von Maspero, J. | Peters, A. | Chapman, K. | +12

2

Real-world effectiveness of dupilumab in patients with asthma : Findings from the US ADVANTAGE study

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2024

von Blaiss, M. | Bleecker, E. | Jacob-Nara, J. | +9

3

Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination

enthalten in: Allergy | 2024

von Valk, A. | Keijser, J. | van Dam, K. | +28

4

Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronavirus Disease 2019 : A Follow-up Study From a Phase 2a Trial

enthalten in: Open forum infectious diseases | 2024

von Hendrick, J. | Ma, J. | Haughey, H. | +8

UpdateOf: medRxiv. 2023 Sep 02;:. - PMID 37693596

5

Mononeuropathy multiplex caused by cutaneous arteritis diagnosed by skin biopsies for emerging atypical erythema on upper limbs following neurological symptoms : a case report

enthalten in: Rinsho shinkeigaku = Clinical neurology | 2024

von Nakamura, Y. | Usami, K. | Taniguchi, T. | +3

6

The effect of dupilumab on clinical outcomes in patients with COVID-19 : A meta-analysis

enthalten in: The Journal of infection | 2023

von Ao, G. | Li, T. | Nasr, B. | +3

7

Efficacy and Safety of Dupilumab in Older Patients (Aged 80 Years and Above) with Atopic Dermatitis : A Prospective Study

enthalten in: Drugs & aging | 2023

von Zhou, X. | Yang, G. | Chen, X. | +1

8

The psychological burden during COVID-19 pandemic in a cohort of patients affected by moderate-to-severe atopic dermatitis treated with dupilumab

enthalten in: Italian journal of dermatology and venereology | 2023

von Quattrini, L. | Chiricozzi, A. | Gori, N. | +6

9

Reply to : 'Severe bullous pemphigoid following Covid-19 vaccination resistant to rituximab and successfully treated with dupilumab' by Baffa et al

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Sun, L. | Brazão, C. | Mancha, D. | +2

CommentOn: J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e135-e137. - PMID 36268775

10

Dupilumab treatment for severe atopic dermatitis in children and SARS-CoV-2 infection : A combination of triggers for psoriasis

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Colonna, C. | Bortoluzzi, P. | Cavalli, R.

1
2
3
4
5
6
7
8
Nächster »
[8]